These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11331704)

  • 1. What happened to primum non nocere?
    Seal JB; Daum RS
    Pediatrics; 2001 May; 107(5):1177-8. PubMed ID: 11331704
    [No Abstract]   [Full Text] [Related]  

  • 2. Balancing risks and benefits: Primum non nocere is too simplistic.
    Halsey NA; Goldman L
    Pediatrics; 2001 Aug; 108(2):466-7. PubMed ID: 11483816
    [No Abstract]   [Full Text] [Related]  

  • 3. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mercury rising: warnings in pregnancy & infancy.
    Ohm J
    Midwifery Today Int Midwife; 2005; (74):46-7, 68. PubMed ID: 16022361
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limiting infant exposure to thimerosal in vaccines and other sources of mercury.
    Halsey NA
    JAMA; 1999 Nov; 282(18):1763-6. PubMed ID: 10568650
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the editor. The safety of thimerosal in newborn and infant vaccines.
    Thompson WW; DeStefano F; Chen R
    Vaccine; 2004 Dec; 23(3):281-2. PubMed ID: 15530668
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.
    Thomas AR; Fiore AE; Corwith HL; Cieslak PR; Margolis HS
    Pediatr Infect Dis J; 2004 Apr; 23(4):313-8. PubMed ID: 15071284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage.
    Luman ET; Fiore AE; Strine TW; Barker LE
    JAMA; 2004 May; 291(19):2351-8. PubMed ID: 15150207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing harm from thimerosal in vaccines.
    Plotkin SA
    JAMA; 2000 Apr; 283(16):2104-5. PubMed ID: 10791499
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing harm from thimerosal in vaccines.
    Offit PA
    JAMA; 2000 Apr; 283(16):2104; author reply 2105. PubMed ID: 10791498
    [No Abstract]   [Full Text] [Related]  

  • 12. From the Centers for Disease Control and Prevention. Impact of the 1999 AAP/USPHS Joint Statement on Thimerosal in Vaccines on Infant Hepatitis B Vaccination Practices. American Academy of Pediatrics/U.S. Public Health Service.
    JAMA; 2001 Mar; 285(12):1568-70. PubMed ID: 11302135
    [No Abstract]   [Full Text] [Related]  

  • 13. Thiomersal in vaccines: is removal warranted?
    Clements CJ; Ball LK; Ball R; Pratt RD
    Drug Saf; 2001; 24(8):567-74. PubMed ID: 11480489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.
    Brayden RM; Pearson KA; Jones JS; Renfrew BL; Berman S
    J Pediatr; 2001 May; 138(5):752-5. PubMed ID: 11343056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonate exposure to thimerosal mercury from hepatitis B vaccines.
    Dórea JG; Marques RC; Brandão KG
    Am J Perinatol; 2009 Aug; 26(7):523-7. PubMed ID: 19283656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of thimerosal use in childhood vaccines.
    Ball LK; Ball R; Pratt RD
    Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thimerosal and vaccines--a cautionary tale.
    Offit PA
    N Engl J Med; 2007 Sep; 357(13):1278-9. PubMed ID: 17898096
    [No Abstract]   [Full Text] [Related]  

  • 18. Thimerosal disappears but autism remains.
    Fombonne E
    Arch Gen Psychiatry; 2008 Jan; 65(1):15-6. PubMed ID: 18180423
    [No Abstract]   [Full Text] [Related]  

  • 19. A review of Thimerosal (Merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness.
    Geier DA; Sykes LK; Geier MR
    J Toxicol Environ Health B Crit Rev; 2007 Dec; 10(8):575-96. PubMed ID: 18049924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACMT position statement: the Iom report on thimerosal and autism.
    Kurt TL
    J Med Toxicol; 2006 Dec; 2(4):170-1. PubMed ID: 18072140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.